ZUNVEYL is approved by the U.S. Food and Drug Administration (FDA) as a cholinesterase inhibitor indicated for the treatment of mild to moderate dementia of the Alzheimer’s type in adults.
Please see the Full Prescribing Information.
Learn more about ZUNVEYL by visiting the product website.